Cervicitis: A review

Current Opinion in Infectious Diseases

Volumn 21, Issue 1, 2008, Pages 49-55

  Lusk, M Josephine ^a   Konecny, Pam ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Bacterial vaginosis; Cervicitis; Mycoplasma; Nonspecific cervicitis; Nucleic acid amplification technique; Pelvic inflammatory disease

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; MOXIFLOXACIN;

ADENOVIRUS; ANTIBIOTIC RESISTANCE; CHLAMYDIA; CHLAMYDIASIS; CYTOMEGALOVIRUS; DIAGNOSTIC PROCEDURE; ENDOMETRITIS; GONORRHEA; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MYCOPLASMA GENITALIUM; MYCOPLASMA HOMINIS; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; OUTCOME ASSESSMENT; PATHOGENESIS; PELVIC INFLAMMATORY DISEASE; PREGNANCY OUTCOME; PREVALENCE; REVIEW; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS; TRICHOMONAS VAGINALIS; UREAPLASMA UREALYTICUM; UTERINE CERVICITIS; UTERINE CERVIX CANCER; VAGINITIS; VIRUS TRANSMISSION; WART VIRUS;

FEMALE; HUMANS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; SEXUALLY TRANSMITTED DISEASES, VIRAL; TRICHOMONAS INFECTIONS; UTERINE CERVICITIS;

EID: 38149029244     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3282f3d988     Document Type: Review

References (69)

1. Brunham R, Paavonen J, Stevens CE, et al. Mucopurulent cervicitis - the ignored counterpart in women of urethritis in men. N Engl J Med 1984; 311:1-6.
2. Marrazzo JM, Martin D. Management of women with cervicitis. Clin Infect Dis 2007; 44 (suppl 3):102-110. This is an excellent, up-to-date, expert discussion of the dilemmas currently faced in defining aetiology, clinical significance and management of cervicitis.
3. Lee DM, Chen MY, Bradshaw CS, Fairley CK. Is routine vaginal examination necessary for asymptomatic women attending sexual health services? Int J STD AIDS 2006; 9:631-633. This study proposes streamlining of STI screening by potentially replacing internal cervical sampling with urinary NAAT testing, challenging current standards of practice.
4. Holmes KK, Stamm WE. Lower genital tract infections in women. In: Holmes KK, Mardh PA, Sparling PF, et al., editors. Sexually transmitted diseases, 3rd ed. New York: McGraw-Hill; 1999. pp. 761-781.
5. Manhart LE, Critchlow CW, Holmes KK, et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Inf Dis 2003; 187:650-657.
6. Marrazzo JM. Mucopurulent cervicitis: no longer ignored, but still misunderstood. Infect Dis Clin N Am 2005; 19:333-349.
7. 2-producing lactobacilli, older age and recent oral sex.
8. Marrazzo JM, Handsfield HH, Whittington WLH. Predicting cervical infection: implications for management of cervicitis. Obstet Gynae 2002; 100:579-584.
9. Nyirjesy P. Nongonococcal and nonchlamydial cervicitis. Curr Infect Dis Rep 2001; 3:540-545.
10. Nugent RP, Hillier SL. Mucopurulent cervicitis as a predictor of Chlamydia infection and adverse pregnancy outcome. Sex Transm Dis 1992; 19:198-202.
11. Bradshaw CS, Tabrizi SN, Read TRH, et al. Etiologies of nongonococcal urethritis: bacteria, viruses and the association of oro-genital exposure. J Inf Dis 2006; 193:336-345. This landmark paper examines the aetiology of the analogous condition of nongonococcal urethritis in men. It provides important data supporting the roles of M. genitalium, adenovirus and HSV-1 in the aetiology of nongonococcal urethritis and provides impetus for similar focus and investigations of the role of these organisms in cervicitis in women.
12. Center for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1-94. This is the latest version of widely accepted guidelines used by clinicians, which undergo continual review and evaluation.
13. Antibiotic Expert Group, Australasian Society of Infectious Diseases. Therapeutic guidelines, antibiotic. Version 13. Melbourne: Australasian Society of Infectious Diseases; 2006. pp. 108-109.
14. Sheeder J, Stevens-Simon C, Lezotte D, et al. Cervicitis: to treat or not to treat? The role of patient preferences and decision analysis. J Adolescent Health 2006; 39:887-892. This article provides a novel approach modelling three algorithms for management of cervicitis addressing the less-explored psychological morbidity of an STI diagnosis and the impact on health in young women. Although this analysis was based on the assumption that nonchlamydial cervicitis did not confer a risk of subsequent morbidity, the need for further clarification of the significance of a diagnosis of 'cervicitis' is highlighted.
15. Paavonen J, Kiviat N, Brunham RC, et al. Prevalence and manifestations of endometritis in women with cervicitis. Am J Obstet Gynecol 1985; 152:280-286.
16. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002; 100:456-463.
17. Currie MJ, Bowden FJ. The importance of chlamydial infections in obstetrics and gynaecology: an update. Aust NZ J Obstet Gynaecol 2007; 47:2-8. This is a very clear, thorough review of the literature on Chlamydia, and the epidemiology, pathophysiology, management, serious reproductive sequelae and strategies for screening of this pathogen.
18. Peipert JF, Ness RB, Soper DE, Bass D. Association of lower genital tract inflammation with objective evidence of endometritis. Infect Dis Obstet Gynecol 2000; 8:83-87.
19. Hakakha MM, Davis J, Korst LM, Silverman NS. Leukorrhea and bacterial vaginosis as in-office predictors of cervical infection in high-risk women. Obstet Gynecol 2002; 100:808-812.
20. Geisler WM, Yu S, Venglarik M, Schwebke JR. Vaginal leucocyte counts in women with bacterial vaginosis: relation to vaginal and cervical infections. Sex Transm Infect 2004; 80:401-405.
21. Bakken IJ, Skjeldestad FE, Nordbo SA. Chlamydia trachomatis infections increase the risk for ectopic pregnancy: a population-based, nested case-control study. Sex Transm Dis 2007; 34:166-169.
22. Ovalle A, Romero R, Gomez R, et al. Antibiotic administration to patients with preterm labor and intact membranes: is there a beneficial effect in patients with endocervical inflammation? J Maternal-fetal Neonat Med 2006; 1:453-464. This interesting study suggests that nonspecific endocervical inflammation (defined as <10 PMNL/hpf) in pregnant women in preterm labour may be a useful clinical marker for women who might benefit from antibiotic intervention.
23. Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of 2 overlapping epidemics. J AIDS 2004; 35:435-445.
24. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of Human Immunodeficieny Virus DNA. J Infect Dis 1994; 170:1597-1601.
25. McClelland RS, Wang CC, Mandaliya K, et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 2001; 15:105-110.
26. Coleman JS, Hitti J, Bukusi EA, et al. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 2007; 21:755-759. This small cross-sectional study demonstrates an association between upper-genital-tract infection (plasma cell endometritis) and increased HIV shedding, which has important implications for heterosexual transmission.
27. Castle PE. Beyond human papillomavirus: the cervix, exogenous secondary factors, and the development of cervical precancer and cancer. J Lower Genital Tract Dis 2004; 8:224-230.
28. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Eng J Med 1992; 327:1272-1278.
29. Castle PE, Hillier SL, Rabe LK, et al. An association of cervical inflammation with high grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 2001; 10:1021-1027.
30. Lukic A, Canzio C, Patella A, et al. Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum. Anticancer Res 2006; 26:4843-4850. This article reviews previous reported associations between cervical organisms and HPV-associated cervical carcinoma. The association of U. urealyticum with increasing level of cervical cellular abnormality in the context of HPV infection suggested a cofactor role for U. urealyticum in oncogenesis.
31. Romoren M, Sundby J, Velauthapillai M. Chlamydia and gonorrhoea in pregnant Botswana women: time to discard the syndromic approach? BMC Infect Dis 2007; 7:27. This is a large, comprehensive evaluation of vaginal signs and symptoms and socio-demographic factors for predicting infection with Chlamydia and N. gonorrhoea in the syndromic management of a population of antenatal women where cervical infection prevalence is around 10% and pathogen testing is not available. The present syndromic algorithms were not found to be satisfactorily predictive, and the authors called for urgent availability of rapid, cheap pathogen testing.
32. Stern JD, Givan AL, Gonzalez JL, et al. Leukocytes in the cervix: a quantitative evaluation of cervicitis. Obstet Gynecol 1998; 91:987-991.
33. Paavonen J, Critchlow CW, DeRouen T, et al. Etiology of cervical infection. Am J Obstet Gynecol 1986; 154:556-564.
34. Critchlow CW, Wolner-Hanssen P, Eschenbach DA, et al. Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking and douching. Am JObstet Gynecol 1995; 173:534-543.
35. Wolner-Hanssen PK, Eschenbach DA, Paavonen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA 1990; 263:1936-1941.
36. Scholes D, Stergachis AS, Ichikawa LE, et al. Vaginal douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet Gynecol 1998; 91:993-997.
37. Ness R, Hillier S, Kip KE, et al. Douching, pelvic inflammatory disease and incident gonococcal and chlamydial genital infection in a cohort of high risk women. Am J Epidem 2005; 161:186-195.
38. Willmott FE. Current smoking habits and genital infections in women. Int J STD AIDS 1992; 3:329-331.
39. Geisler WM, Suchland RJ, Rockey DD, Stamm WE. Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy non-fusogenic inclusions. J Infect Dis 2001; 184:879-884.
40. Falk L, Fredlund H, Jensen JS. Signs and symptoms of urethritis and cervicitis among women with and without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect 2005; 8:73-78.
41. Schlicht MJ, Lovrich SD, Satin JS, et al. High prevalence of genital Mycoplasmas among sexually active young adults with urethritis or cervicitis in La Crosse, Wisconsin. J Clin Microbiol 2004; 42:4636-4640.
42. Ross JDC, Jensen JS. Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing and treatment. Sex Transm Infect 2006; 82:269-271. This expert review covers the evidence for M. genitalium being considered an STI. The authors felt testing for M. genitalium is warranted in symptomatic patients, with the need for standardized testing kits and specific treatment.
43. Taylor-Robinson D. Mycoplasma genitalium - an update. Int J STD AIDS 2002; 13:145-151.
44. Cohen CR, Manhart LE, Bukusi EA, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359:765-766.
45. Taylor-Robinson D. The role of Mycoplasmas in pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007; 21:425-438. The most comprehensive update of M. genitalium, M. hominis and Ureaplasma species and bacterial vaginosis and their role in female genital tract disease and adverse pregnancy outcome.
46. Svenstrup HF, Fedder J, Kristoffersen SE, et al. Mycoplasma genitalium, Chlamydia trachomatis and tubal factor infertility - a prospective study. Fertil Steril 2007 (Epub ahead of print). Given the importance of dwindling fertility rates in developed countries worldwide, this is a very topical study linking M. genitalium with tubal factor infertility.
47. Jurstrand M, Jensen JS, Magnuson A, et al. A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy. Sex Transm Infect 2007; 83:319-323. This is another very topical investigation into the potential relationship of M. genitalium with PID and ectopic pregnancy. It is limited by small study size and the use of stored serum.
48. Andersen B, Sokolowski I, Ostergaard L, et al. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect 2007; 83:237-241. This is an excellent, large prevalence study in women and men using samples from a previous population-based study, with thoughtful discussion of topical issues.
49. Oakeshott P, Hay P, Taylor-Robinson D, et al. Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome. Br J Obstet Gynaecol 2004; 111:1464-1467.
50. Labbe A-C, Frost E, Deslandes S, et al. Mycoplasma genitalium is not associated with adverse outcomes of pregnancy in Guinea-Bassau. Sex Transm Infect 2002; 78:289-291.
51. Haggerty CL, Totten PA, Astete SG, Ness RB. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynaecol 2006; article ID 30184:1-5.
52. Korte JE, Baseman JB, Cagle MP, et al. Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. Am J Reprod Immunol 2006; 55:265-275.
53. Waites KB, Katz B, Schelonka RL. Mycoplasmas and Ureaplasmas as neonatal pathogens. Clin Microbiol Rev 2005; 18:757-789.
54. Schwebke JR, Weiss HL. Interrelationships of bacterial vaginosis and cervical inflammation. Sex Transm Dis 2002; 29:59-64.
55. Haggerty CL, Hillier SL, Bass DC, Ness RB. Bacterial vaginosis and anaerobic bacteria are associated with endometriosis. Clin Infect Dis 2004; 39:990-995.
56. Ness RB, Hillier SL, Kip KE, et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 2004; 104:761-769.
57. Yudin MH, Landers DV, Meyn L, et al. Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol 2003; 102:527-534.
58. Olmsted SS, Meyn LA, Rohan LC, et al. Glycosidase and proteinase activity of anaerobic gram negative bacteria isolated from women with bacterial vaginosis. Sex Transm Dis 2003; 30:257-261.
59. Mitunari M, Yoshida S, Deura I, et al. Cervical Ureaplasma urealyticum colonization might be associated with increased incidence of preterm delivery in pregnant women without prophogistic microorganisms on routine examination. J Obstet Gynaecol Res 2005; 31:16-21.
60. McGalie CE, McBride HA, McCluggage WG. Cytomegalovirus infection of the cervix: morphological observations in 5 cases of a possibly underrecognised condition. J Clin Pathol 2004; 57:691-694.
61. Daxnerova Z, Berkova Z, Kaufman RH, Adam E. Detection of human cytomegalovirus DNA in 986 women studied for human papillomavirus-associated cervical neoplasia. J Lower Genital Tract Dis 2003; 7:187-193.
62. Clarke LM, Duerr A, Feldmen J, et al. Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1 seronegative and seropositive women from an urban minority community. J Infect Dis 1996; 173:77-82.
63. McIver CJ, Jacques CFH, Chow SW, et al. Development of multiplex PCRs for detection of common viral pathogens and agents of congenital infections. J Clin Micro 2005; 43:5102-5110.
64. Swenson PD, Lowens MS, Celum CL, Hierholzer JC. Adenovirus types 2,8 and 37 associated with genital infections in patients attending a sexually transmitted disease clinic. J Clin Microbiol 1995; 33:2728-2731.
65. McClelland RC, Sangere L, Hassan WM. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698-702. In response to lack of a demonstratable link between trichomoniasis and HIV-1 acquisition in previous studies, the authors analysed data from a large 11-year prospective study of female sex workers in Nairobi. They demonstrated a 1.5-fold (adjusted) increased risk of HIV acquisition with trichomoniasis, which was also associated with cervicitis, a significant result given the relatively high Trichomonas prevalence in resource-limited settings.
66. Gaydos CA. Rapid tests for sexually transmitted diseases. Curr Infect Dis Rep 2006; 8:115-124. This is a highly topical discussion of the advances made in new generation point-of-care (POC) bedside test kits for STI screening, particularly for use in resource and laboratory-poor settings.
67. Bradshaw CS, Jensen J, Tabrizi S, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12:1149-1151. Increased minimum inhibitory concentrations to azithromycin were demonstrated in this study. The researchers have pursued the aetiology of persistent nonspecific urethritis and widened the horizons of STI research.
68. Dalgic H, Kuscu NK. Laser therapy in chronic cervicitis. Arch Gynecol Obstet 2001; 265:64-66.
69. Haggerty CL, Ness RB. Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. Clin Infect Dis 2007; 44:953-960. This comprehensive review of more recent randomized controlled trials examines the efficacy of treatment regimens for PID. The authors (and the accompanying editorial commentary) emphasized the need to focus upon gynaecological and reproductive outcomes, rather than a short-term clinical and microbiological cure.